Janus Henderson has launched the Global Life Sciences Equity fund, allowing access to its US namesake strategy to UK investors.
The fund will take positions in firms addressing what it describes as "unmet medical needs" or "aimed at maintaining or improving quality of life". The strategy will aim to outperform the MSCI World Health Care index by at least 2% per annum over the course of a market cycle. Where are the opportunities to invest in 21st century healthcare? The established Janus Henderson Global Life Sciences strategy was founded over two decades ago and managers of the US-domiciled sister Global Life Sciences offering, Andy Acker and Dan Lyons, will both oversee the new UK-listed portfolio. Acker ...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
